An edition of Improving predictability and transparency in DEA and FDA regulation (2015)

Improving predictability and transparency in DEA and FDA regulation

hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014

By United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health